Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539268 | NSE Symbol : SYNGENE | ISIN : INE398R01022 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
13-Jan-2025	23-Jan-2025	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ending December 31 2024 amongst other routine matters. Outcome of the Board Meeting - January 23, 2025 (As Per BSE Announcement Dated on: 23/01/2025)
04-Oct-2024	23-Oct-2024	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30 2024 amongst other routine matters. Outcome of the Board Meeting - October 23, 2024. (As Per BSE Announcement dated on 23.10.2024)
28-Jun-2024	24-Jul-2024	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter ending June 30 2024 amongst other routine matters Outcome of the Board Meeting - July 24, 2024. (As per BSE Announcement Dated on 24/07/2024)
01-Apr-2024	24-Apr-2024	Accounts	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ending March 31 2024; and to consider the recommendation of final dividend if any. The Board of Directors recommends Final Dividend of Rs. 1.25/- per share. Outcome of the Board Meeting - April 24, 2024 Audited Financial Results for the quarter and year ended March 31, 2024. The Board of Directors recommends Final Dividend of Rs. 1.25/- per share. Allotment of shares under Syngene Restricted Stock Units Long Term Incentive Plan FY 2020. (As Per BSE Announcement dated on 24.04.2024)
26-Dec-2023	25-Jan-2024	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended on December 31 2023. the unaudited standalone and consolidated financial results for the quarter and nine months ended on December 31 2023. Outcome of the Board Meeting - January 25, 2024 Unaudited Financial Results for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 25/01/2024)
06-Oct-2023	17-Oct-2023	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2023 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended on September 30, 2023. Unaudited Financial Results for quarter and half year ended September 30, 2023. Outcome of the Board Meeting - October 17, 2023. (As Per BSE Announcement Dated on 17/10/2023)
13-Jul-2023	26-Jul-2023	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended on June 30 2023. Unaudited Financial Results for quarter ended June 30, 2023. Outcome of the Board Meeting - June 30, 2023. (As Per BSE Announcement dated on 26.07.2023)
07-Apr-2023	26-Apr-2023	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2023 inter alia to consider and approve the audited standalone and consolidated financial results for the 4th quarter and year ended on March 31 2023 and to consider the recommendation of final dividend if any amongst other routine matters. Board approved:- 1. The Board recommended a final dividend of Re. 1.25/- per Equity Share of Rs. 10/-(comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.75 per share to mark the 30th anniversary of the founding of the Company in November 1993) subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The record date is fixed as Friday, June 30, 2023 for payment of dividend. The dividend will be paid within 30 days from the date of shareholders' approval. Annual General Meeting: 2. Cconvening of the 30th Annual General Meeting of the Company on Wednesday, July 26, 2023 (As Per BSE Bulletin Dated on 26.04.2023) Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2023. Outcome of the Board Meeting - April 26, 2023. (As per BSE Announcement Dated on 26/04/2023)
06-Jan-2023	23-Jan-2023	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31 2022. Outcome of the Board Meeting - January 23, 2023 Un-audited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2022 (As per BSE Announcement Dated on 23/01/2023)
06-Oct-2022	19-Oct-2022	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2022 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended on September 30 2022. Outcome of the Board Meeting - October 19, 2022. Unaudited Financial Results for the quarter and half year ended September 30, 2022. (As Per BSE Announcement Dated on 19.10.2022) In continuation to our letter dated October 19, 2022, regarding outcome of the Board Meeting and financials for the quarter and half year ended September 30, 2022, please find enclosed herewith the copy of newspaper publication of the financials in Financial Express (All India Edition) and Vijayavani (Bengaluru Edition) published on October 20, 2022. (As Per BSE Announcement Dated on 20/10/2022)
04-Jul-2022	20-Jul-2022	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2022 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended on June 30 2022. Pursuant to the above the trading window for dealing in securities of the Company for all Insiders as defined under the Code of Conduct for Prevention of Insider Trading of the Company has been closed from July 01 2022 to July 22 2022 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. Outcome of the Board Meeting - July 20, 2022 Outcome of the Board Meeting - July 20, 2022 (As Per BSE Announcement Dated on 20.07.2022)
05-Apr-2022	27-Apr-2022	Final Dividend	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2022 inter alia to consider and approve Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the meeting of the Board of Directors of the Company will be held on Wednesday April 27 2022 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended on March 31 2022 and to consider the recommendation of final dividend if any amongst other routine matters. Pursuant to the above the trading window for dealing in securities of the Company for all Insiders as defined under the Code of Conduct for Prevention of Insider Trading of the Company has been closed from April 01 2022 to April 29 2022 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered and approved the following: 1. Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.50 per share) for the Financial year March 31, 2022 subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days from the date of shareholders' approval at the ensuing Annual General Meeting. 2. Approved convening of 29th Annual General Meeting of the Company on July 20, 2022. Outcome of the Board Meeting Allotment (As Per BSE Announcement Dated on 27.04.2022) Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered and approved the following: 1. Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.50 per share) for the Financial year March 31, 2022 subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days from the date of shareholders' approval at the ensuing Annual General Meeting. 2. Approved convening of 29th Annual General Meeting of the Company on July 20, 2022. (As per BSE Announcement Dated on 28/4/2022)
04-Jan-2022	19-Jan-2022	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2022 inter alia to consider and approve Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the meeting of the Board of Directors of the Company will be held on Wednesday January 19 2022 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended on December 31 2021. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the following: Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the following: Financial Results: Un-audited financial results (consolidated and standalone) as per Indian Accounting Standards (Ind-AS) for the quarter and nine months ended December 31, 2021. A copy of the un-audited financial results along with the Limited Review Reports is enclosed herewith. (As Per BSE Announcement dated on 19.01.2022) In continuation to our letter dated January 19, 2022, regarding outcome of the Board Meeting and financials for the quarter and nine months ended December 31, 2021, please find enclosed herewith the copy of newspaper publication of the financials in Financial Express (All India Edition) and Vijayavani (Bengaluru Edition) on January 21, 2022. (As Per BSE Announcement Dated on 21/01/2022)
04-Oct-2021	20-Oct-2021	Half Yearly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2021 ,inter alia, to consider and approve Pursuant to regulation 29(1) of SEBI (LODR) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, October 20, 2021, inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended on September 30, 2021. Pursuant to the above, the trading window for dealing in securities of the Company for all Insiders, as defined under the Code of Conduct for Prevention of Insider Trading of the Company, has been closed from October 01, 2021 to October 22, 2021 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The Company will organize a conference call for analysts and investors on Thursday, October 21, 2021. The details of the same will be available on the Company's website closer to the scheduled event. The above-mentioned information will also be available on website of the Company www.syngeneintl.com. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the following: (As Per BSE Announcement dated on 20.10.2021)
07-Jul-2021	20-Jul-2021	Quarterly Results	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2021 ,inter alia, to consider and approve Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, July 20, 2021, inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2021. Pursuant to the above, the trading window for dealing in securities of the Company for all Insiders, as defined under the Code of Conduct for Prevention of Insider Trading of the Company, has been closed from July 01, 2021 to July 22, 2021 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the following: Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the following: Financial Results: Un-audited financial results (consolidated and standalone) as per Indian Accounting Standards (Ind-AS) for the quarter ended June 30, 2021. A copy of the un-audited financial results along with the Limited Review Reports is enclosed herewith. (As Per BSE Announcement Dated 20.07.2021)

1 2

LOGIN HERE

Syngene International Ltd

Board Meeting